Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Chih Ping Han"'
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 63, Iss 1, Pp 125-126 (2024)
Externí odkaz:
https://doaj.org/article/89ce8ef360734a42a6aa989643f2df70
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 62, Iss 2, Pp 384-386 (2023)
Externí odkaz:
https://doaj.org/article/c73fd6140894461aa7baceb16d36dd3a
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 6, Pp 1072-1077 (2021)
Objective: Considering the clinical evidence of BRAF inhibitors that can treat melanoma patients successfully, we aimed to investigate the status of BRAF mutations of primary mucinous ovarian carcinomas (MOC) in Taiwanese women, and apply the emergin
Externí odkaz:
https://doaj.org/article/66c222cbda7c46129dc0f794551f56e6
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 61, Iss 3, Pp 566-567 (2022)
Externí odkaz:
https://doaj.org/article/f093720d87d84c6d99f68b70b807216f
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 59, Iss 2, Pp 346-347 (2020)
Externí odkaz:
https://doaj.org/article/bffd958f3ca3400b88f153beb8920653
Publikováno v:
Virchows Archiv. 480:1023-1030
The successful experiences of HER2 inhibitors in patients with HER2 ( +) breast cancer (BC) and advanced gastroesophageal adenocarcinoma (GEA) have encouraged us to continuously explore the HER2 status and its potential as a therapeutic target in pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb150422d48fb3dc65f5e431740816a9
https://doi.org/10.1007/s00428-022-03285-9
https://doi.org/10.1007/s00428-022-03285-9
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 6, Pp 1072-1077 (2021)
Objective Considering the clinical evidence of BRAF inhibitors that can treat melanoma patients successfully, we aimed to investigate the status of BRAF mutations of primary mucinous ovarian carcinomas (MOC) in Taiwanese women, and apply the emerging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ed0bd6b1d3596d4c4a2e39fc157063
https://doi.org/10.1016/j.tjog.2021.09.019
https://doi.org/10.1016/j.tjog.2021.09.019
Publikováno v:
Journal of cancer research and therapeutics. 18(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3394dd1597572c040b0615fe338593a
https://pubmed.ncbi.nlm.nih.gov/35900578
https://pubmed.ncbi.nlm.nih.gov/35900578
Autor:
Wan-Ru Chao, Ming-Yung Lee, Alexandra Ruan, Huang Pin Sheng, Jeng-Dong Hsu, Chih-Ping Han, Chiew-Loon Koo
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142135 (2015)
We aimed to compare the assay performance characteristics of HER2 status in mucinous epithelial ovarian cancer (EOC) by ToGA (Trastuzumab for Gastric Cancer) biopsy versus ToGA surgical specimen methods. Forty-nine tissue microarray (TMA) samples of
Externí odkaz:
https://doaj.org/article/2fb182d6562d474fa49e9b1b729374c6
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 55, Iss 5, Pp 741-742 (2016)
Externí odkaz:
https://doaj.org/article/f19f04fd9b5544d7876214aacb83e512